Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We have established an ex vivo mast cell degranulation assay carried out by incubating crude peritoneal exudate cells isolated from the mice, treated with a pharmacological agent of interest and administered anti-dinitrophenol (DNP) IgE beforehand, with DNP on a carrier protein.

Abstract

Mast cell stabilizers are an essential part of allergy medication. Passive systemic anaphylaxis (PSA) is an animal assay widely used for investigating the effect of a pharmacological agent of interest on mast cells in vivo. As the anaphylactic symptoms are primarily attributed to exocytosis of the granules from mast cells, it is conceived that the agent to cause amelioration of the symptoms has a mast cell stabilizing activity. Despite the fact, it is prudent to confirm the activity by directly demonstrating the decline in the functional activity of mast cells following its treatment. In vitro degranulation assays using an immortalized mast cell line or cultured primary mast cells are routinely employed to that end. The results from the in vitro and in vivo assays may not always be akin to each other; however, as treatment conditions (e.g., treatment dose, time, surrounding environments) for the in vitro assays are often distinct from those for the in vivo assay such as PSA. In pursuit of an in vitro (or ex vivo) assay to reflect more closely the effect of a pharmacological agent on mast cells in vivo, we devised the ex vivo mast cell degranulation assay in which crude peritoneal exudate cells (PECs) isolated from the mice, treated with the agent and administered anti-dinitrophenol (DNP) IgE, were incubated directly with DNP on a carrier protein. It turned out that the assay was not only useful in validating the mast cell stabilizing activity of a pharmacological agent indicated by the in vivo assay but also practical and highly reproducible.

Introduction

Mast cells play a central role in allergy1,2. When IgE located on the surface of mast cells via interaction with the high-affinity receptor for IgE (FcεRI) encounters a cognate allergen, a signaling cascade is elicited to prompt the release of the granules. As a result, a variety of allergy effector molecules, including monoamines (e.g., histamine, serotonin), cytokines (e.g., TNF-α), and proteolytic enzymes (e.g., tryptase, chymase), are released to cause a series of immunological, neurological and vasomuscular reactions3,4.

Protocol

All animal experiments were performed in accordance with the guideline provided by the IACUC (Institutional Animal Care and Use Committee) of Chungnam National University (Animal Protocol Number: CNU-00996).

1. Quantifying mast cell-specific molecules in the lysate of crude PECs

  1. Isolate the cells from the mouse peritoneal cavity12.
    1. Anesthetize a mouse (8 weeks old, male, BALB/C) with isoflurane. Euthanize via cervical dislocation.
    2. Plac.......

Representative Results

Determining the optimal number of PECs for ex vivo mast cell degranulation assay

Mast cells (c-kit+·IgE+ double positive cells)15 represent only about 2% of PECs (Figure 1A). Estimating the maximum levels of mast cell-specific molecules to be detected in the culture supernatants on the assumption that 100% of the granules were released by mast cells in PECs, we measured the amounts of β-hexos.......

Discussion

The finding that mast cell degranulation assay can be carried out with a relatively small number of crude mouse PECs is significant. Even though PECs must be an excellent source of primary mouse mast cells, it is demanding to purify mast cells in PECs. Although a density gradient media such as Percoll25 has been successfully used for purification of mast cells from rat PECs, its use for purification of mouse peritoneal mast cells has been limited presumably for the difference in the densities of r.......

Acknowledgements

We thank Mr. Wonhee Lee and Ms. Eunjoo Lee for their technical and administrative assistance. We also thank Dr. Thi Minh Nguyet Nguyen for her thoughtful comments. This work was supported by the research grants from Chungnam National University (CNU Research Grant 2017-2098-01) and from National Research Foundation of Korea (NRF-2019R1F1A1061894 and NRF-2019M3A9G4067293).

....

Materials

NameCompanyCatalog NumberComments
1 mL syringe1757589701
1.5 mL micro tubeHisolMT-15003
10 mL syringe1757593161
15 mL conical tubeThermo Fisher scientific14-959-53A
20xPBSTech & InnovationBPB-9121-500mL
4-nitrophenyl-N-acetyl-β-D-glucosaminideSIGMAN9376
5 mL polystyrene round-bottom tubeLife sciences352003
50 mL conical tubeThermo Fisher scientific14-959-49A
Aluminium FiolBioFactTS1-3330
Anti-mouse CD117(c-kit)Biolegend135129keep at 2-8°C
Anti-mouse IgE mAbsThermo Fisher scientific11-5992-81keep at 2-8°C
Antiti-DNP-IgESIGMAD8406-.2MGkeep at -20°C
CentrifugeHANIL396150
D-(+)-gluouseSIGMAG8270
DexamethasoneSIGMAD2915-100MG
DNP-BSAInvitrogen2079360keep at -20°C
EDTABiofactPB131-500
Fetal Bovine serumThermo Fisher scientific11455035
GelatinSIGMAG1890
GlycineJUNSEI27185-0350
hemocytometerZEISS176045
HEPESThermo Fisher scientific15630130
Histamine ELISA kitAbcamGK3275957-4keep at 2-8°C
Hotplate stirrerLab teachzso-9001
IsofluranceTroikaaI29159
ketotifen fumarate saltSIGMAK2628
MCPT-1 ELISA kitThermo Fisher scientific88-7503-22keep at 2-8°C
Mouse Fc blockBD Biosciences553141keep at 2-8°C
Propidium iodioleSIGMA81845keep at 2-8°C
RBC lysis bufferBiolegend420301
Round-bottom 96 wellSPL-life sciences30096
Single use syringe filterStartoriusag16555
Streptavidin microbeadsMilteryiBiotec130-048-101keep at 2-8°C
Triton X-100JUNSEIchemical49415-1601
TWEEN 20SIGMA9005-64-5
Water bathCHANGSHINSCIENCE190107

References

Explore More Articles

Mast Cell DegranulationEx Vivo AssayPeritoneal Exudate CellsPassive Systemic AnaphylaxisMast Cell StabilizersAnti dinitrophenol IgEIn Vitro AssayIn Vivo AssayPharmacological Agent

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved